Clinical trials, Yellow cards, Chemo brain, C...

Insulin has been used to treat type 1 diabetes for more than a century but now there is a new treatment being rolled out on the NHS that can delay the onset of the disease for years. Alongside, screening is gathering pace, identifying those that could benefit. So, is this the beg ...  Show more

More than six years since the start of the Covid pandemic, it might feel like we're pretty over it, yet that's simply not the case for the millions of people who suffer from long Covid. But could there be hope on the horizon? A new clinical trial led by University College London ...  Show more

Why does one child become rebellious and another not? Claudia Hammond talks to Mark McDermott from the University of East London about new research into parenting and rebelliousness. She also hears from another shortlisted entry to the All in the Mind mental health awards. Plus, ...  Show more

JAMA Associate Editor Ethan Basch, MD, and Melanie Calvert, PhD, from the University of Birmingham, UK, discuss barriers to and strategies for including rigorous patient-reported outcomes in clinical trials, and reflect on Dr Calvert's recent JAMA paper on related ethical impl ...

A new medication for psychosis is on the horizon. It's called KarXT and it could mean fewer side effects as well as finally some relief from difficulties with attention, concentration and memory - these are the symptoms patients often report as having the greatest impact on their ...  Show more

Three leading researchers from the Mount Sinai Health System discuss how ketamine, cannabis, and ecstasy are being used (or studied) to treat everything from severe depression to addiction to PTSD. We discuss the upsides, downsides, and regulatory puzzles.

Hosted b ...